The Impact of Androgen Receptor Expression on Neoadjuvant Therapy in HER2-Positive Breast Cancer
Breast Cancer: Targets and Therapy · 2026-05 · Volume 18 · 1-16
DOI: 10.2147/bctt.s595222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-05. Verfasst von Cheng Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing …. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
ORCID-Profile: Haochen Yu
Zitieren
APA
Tian, C., Qiu, J., Fan, Y., Yu, H., & Liu, S. (2026). The Impact of Androgen Receptor Expression on Neoadjuvant Therapy in HER2-Positive Breast Cancer. Breast Cancer: Targets and Therapy, Volume 18, 1-16. https://doi.org/10.2147/bctt.s595222
Vancouver
Tian C, Qiu J, Fan Y, Yu H, Liu S. The Impact of Androgen Receptor Expression on Neoadjuvant Therapy in HER2-Positive Breast Cancer. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-16. doi:10.2147/bctt.s595222
BibTeX
@article{Tian2026,
author = {Tian, Cheng and Qiu, Jihan and Fan, Yanjia and Yu, Haochen and Liu, Shengchun},
title = {The Impact of Androgen Receptor Expression on Neoadjuvant Therapy in HER2-Positive Breast Cancer},
journal = {Breast Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 18},
pages = {1--16},
doi = {10.2147/bctt.s595222}
}
EUVIMED